z-logo
Premium
Microparticles bearing RGD peptide promote integrin αvβ3‐dependent platelet adhesion in isolated, pressurized cerebral artery
Author(s) -
Bagi Zsolt,
PerezBalderas Francisco,
Broskova Zuzana,
Davis Benjamin,
Anthony Daniel
Publication year - 2013
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.27.1_supplement.lb494
Subject(s) - platelet , integrin , adhesion , chemistry , peptide , biophysics , microbiology and biotechnology , medicine , immunology , biochemistry , receptor , biology , organic chemistry
Platelet‐derived microvesicles (PMVs, <500 nm) play a role in thrombotic diseases. How PMVs promote platelet adhesion is poorly understood. To dissect mechanisms we established a method for real‐time imaging of microparticle (MP) and platelet adhesion in intact, perfused arteries. Platelets, with or without prior administration of arginine‐glycine‐aspartate (RGD)‐coated, ironoxide MPs (RGD‐MP, ~700nm, Alexa‐488‐enriched) were delivered intraluminally into isolated, pressurized rat cerebral artery. Individual binding events were observed with high‐speed fluorescence imaging under constant flow (10 μl/min). We detected firm binding of RGD‐MPs on endothelium surface (130±51/mm2), which was reduced by adhesion‐blocking integrin αv antibody. RGD‐MP binding was enhanced (290±73/mm2) by pro‐inflammatory cytokine TNF, which also increased vascular expression of integrin αv. Endothelial adhesion of platelets was 14±3 event/mm2 in naïve arteries, which significantly increased by TNF (48±10/mm2). Prior administration of RGD‐MPs induced greater adhesion of platelets in naïve arteries (78±10/mm2), whereas RGD peptide solution or scrambled RDG peptide‐coated MPs had no effect. Thus, we demonstrate the multivalent RGD‐MP ‐ compared to free ligand in form of RGD peptide ‐ as a more effective construct to promote αvβ3‐dependent adhesion of platelets in the intact cerebral artery.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here